236
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Evaluation of circ_100219 and miR-135b in serum and exosomes of healthy pregnant women

ORCID Icon, , , ORCID Icon, ORCID Icon, , , , , ORCID Icon, & ORCID Icon show all
Pages 3645-3650 | Received 27 May 2019, Accepted 03 Nov 2019, Published online: 13 Nov 2019

References

  • Neiger R. Long-term effects of pregnancy complications on maternal health: a review. J Clin Med. 2017;6(8). pii: E76.
  • Vogel JP, Souza JP, Mori R, et al. Maternal complications and perinatal mortality: findings of the World Health Organization multicountry survey on maternal and newborn health. BJOG. 2014;121(Suppl 1):76–88.
  • Cuffe JSM, Holland O, Salomon C, et al. Review: placental derived biomarkers of pregnancy disorders. Placenta. 2017;54:104–110.
  • Locktich G. Clinical biochemistry of pregnancy. Crit Rev Clin Lab Sci. 1997;34:6.
  • Manokhina I, Wilson SL, Robinson WP. Noninvasive nucleic acid-based approaches to monitor placental health and predict pregnancy-related complications. Am J Obstet Gynecol. 2015;213(4):S197–S206.
  • Sifakis S, Koukou Z, Spandidos DA. Cell-free fetal DNA and pregnancy-related complications (review). Mol Med Rep. 2015;11(4):2367–2372.
  • Cretoiu D, Xu J, Xiao J, et al. Circulating microRNAs as potential molecular biomarkers in pathophysiological evolution of pregnancy. Dis Markers. 2016;2016:1.
  • Montagnana M, Danese E, Lippi G, et al. Blood laboratory testing for early prediction of preeclampsia: chasing the finish line or at the starting blocks? Ann Med. 2017;49(3):240–253.
  • Jairajpuri DS, Malalla ZH, Mahmood N, et al. Circulating microRNA expression as predictor of preeclampsia and its severity. Gene. 2017;627:543–548.
  • Qin W, Tang Y, Yang N, et al. Potential role of circulating microRNAs as a biomarker for unexplained recurrent spontaneous abortion. Fertil Steril. 2016;105(5):1247–1254.e3.
  • Qu S, Yang X, Li X, et al. Circular RNA: a new star of noncoding RNAs. Cancer Lett. 2015;365(2):141–148.
  • Hansen TB, Jensen TI, Clausen BH, et al. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495(7441):384–388.
  • Chim SS, Shing TK, Hung EC, et al. Detection and characterization of placental microRNAs in maternal plasma. Clin Chem. 2008;54(3):482–490.
  • Lü L, Sun J, Shi P, et al. Identification of circular RNAs as a promising new class of diagnostic biomarkers for human breast cancer. Oncotarget. 2017;8(27):44096–44107.
  • Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta C(T)) method. Methods. 2001;25(4):402–408.
  • Ilekis JV, Tsilou E, Fisher S, et al. Placental origins of adverse pregnancy outcomes: potential molecular targets: an executive workshop summary of the Eunice Kennedy Shriver National Institute of Child Health and Human Development. Am J Obstet Gynecol. 2016;215(1):S1–S46.
  • Vashukova ES, Glotov AS, Fedotov PV, et al. Placental microRNA expression in pregnancies complicated by superimposed pre-eclampsia on chronic hypertension. Mol Med Rep. 2016;14(1):22–32.
  • Ark M, Yilmaz N, Yazici G, et al. Rho-associated protein kinase II (rock II) expression in normal and preeclamptic human placentas. Placenta. 2005;26(1):81–84.
  • Lartey J, López Bernal A. Rho protein regulation of contraction in the human uterus. Reproduction. 2009;138(3):407–424.
  • Ietta F, Wu Y, Winter J, et al. Dynamic HIF1A regulation during human placental development. Biol Reprod. 2006;75(1):112–121.
  • Bounds KR, Chiasson VL, Pan LJ, et al. MicroRNAs: new players in the pathobiology of preeclampsia. Front Cardiovasc Med. 2017;4:60.
  • Memczak S, Jens M, Elefsinioti A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013;495(7441):333–338.
  • Xia Q, Ding T, Zhang G, et al. Circular RNA expression profiling identifies prostate cancer- specific circRNAs in prostate cancer. Cell Physiol Biochem. 2018;50(5):1903–1915.
  • Quan G, Li J. Circular RNAs: biogenesis, expression and their potential roles in reproduction. J Ovarian Res. 2018;11(1):9.
  • Qian Y, Lu Y, Rui C, et al. Potential significance of circular RNA in human placental tissue for patients with preeclampsia. Cell Physiol Biochem. 2016;39(4):1380–1390.
  • Wang W, Feng L, Zhang H, et al. Preeclampsia up-regulates angiogenesis-associated microRNA (i.e., miR-17, –20a, and –20b) that target ephrin-B2 and EPHB4 in human placenta. J Clin Endocrinol Metab. 2012;97(6):E1051–E1059.
  • Zhang YG, Yang HL, Long Y, et al. Circular RNA in blood corpuscles combined with plasma protein factor for early prediction of pre-eclampsia. BJOG: Int J Obstet Gynecol. 2016;123(13):2113–2118.
  • Prefumo F. Circular RNA and pre-eclampsia: on the long road from the laboratory to the bedside. BJOG: Int J Obstet Gynecol. 2016;123(13):2119.
  • Lippi G, Simundic AM. The preanalytical phase in the era of high-throughput genetic testing. What the future holds. Diagnosis (Berl). 2019;6:73–74.
  • Tian F, Shen Y, Chen Z, et al. No significant difference between plasma miRNAs and plasma-derived exosomal miRNAs from healthy people. Biomed Res Int. 2017;2017:1.
  • Zavesky L, Jandakova E, Turyna R, et al. Supernatant versus exosomal urinary microRNAs. Two fractions with different outcomes in gynaecological cancers. Neoplasma. 2016;63(01):121–132.
  • Chevillet JR, Kang Q, Ruf IK, et al. Quantitative and stoichiometric analysis of the microRNA content of exosomes. Proc Natl Acad Sci USA. 2014;111(41):14888–14893.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.